Human papillomaviruses and oral neoplasia

European Journal of Cancer. Part B: Oral Oncology

Volumn 28, Issue 1, 1992, Pages 61-66

  Yeudall, W A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MOUTH CANCER; PAPILLOMA VIRUS; REVIEW; VIRUS CELL TRANSFORMATION;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, VIRAL; HUMAN; MOUTH NEOPLASMS; PAPILLOMAVIRUS;

EID: 0026637805     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(92)90015-S     Document Type: Article

References (89)

1. Heterogeneity of the human papillomavirus group
2. Epidermodysplasia verruciformis
3. Epidermodysplasia verruciformis: a model for the role of papillomaviruses in human cancer
4. HPV-5 DNA in a carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types
5. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis
6. Biology and biochemistry of papillomaviruses
7. Immune status as a determinant of human papillomavirus and its association with anal epithelial abnormalities
8. Presence of human papillomavirus in genital tumours
9. Molecular cloning and characterisation of human papillomavirus DNA derived from a laryngeal papilloma
10. Viral etiology of juvenile and adult onset squamous papilloma of the larynx
11. Presence of human papillomavirus type 16 related sequences in verrucous carcinoma of the larynx
12. Molecular cloning and characterisation of the DNA of a new human papillomavirus (HPV-30) from a laryngeal carcinoma
13. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents
14. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions
15. A new type of papillomavirus DNA, its presence in genital cancer and in cell lines derived from cervical carcinoma
16. A novel type of human papillomavirus associated with genital neoplasias
17. A new type of papillomavirus associated with cancer of the uterine cervix
18. Papillomaviruses in human cancers
19. Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity
20. Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma
21. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
22. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells
23. Transformation of primary human fibroblast cells with human papillomavirus type 16 DNA and EJ-ras
24. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA
25. Characterization of primary human keratinocytes transformed by human papillomavirus type 18
26. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma
27. Induction of human squamous cell carcinoma by sequential transfection with human papillomavirus type 16 DNA and viral Harvey ras
28. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells
29. A viral-cellular junction fragment from a human papillomavirus type 16-positive tumor is competent in transformation of NIH3T3 cells
30. Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras
31. Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein
32. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells
33. The upstream regulatory region of the human papillomavirus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones
34. Amplification and overexpression of c-myc proto-oncogene correlate with the loss of glucocorticoid dependence in rodent cells transformed by human papillomavirus type 16
35. Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth factor responsiveness to mouse cells transformed by human papilloma virus type 16
36. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression
37. A point mutational analysis of human papillomavirus type 16 E7 protein
38. Papillomavirus polypeptides E6 and E7 are zinc-binding proteins
39. Mutational analysis of human papillomavirus type 16 E7 functions
40. Comparison of the in vitro transforming activities of human papillomavirus types
41. Co-transformation by human papillomavirus types 6 and 11
42. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1a
43. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product
44. Association between an oncogene and an anti-oncogene: the adenovirus E1a proteins bind to the retinoblastoma gene product
45. SV40 large tumour antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
46. Functional similarity between HPV16 E7, SV40 large T and adenovirus E1a proteins
47. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation
48. Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences
49. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
50. Association of human papillomavirus type 16 and 18 E6 proteins with p53
51. T antigen is bound to a host protein in SV40-transformed cells
52. The adenovirus E1b-55Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54K cellular protein
53. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
54. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18
55. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and transactivation
56. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
57. p53 point mutation in HPV negative human cervical carcinoma cell lines
58. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor
59. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus
60. Human papillomavirus type 16 DNA in normal human ectocervix
61. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer
62. Papillomavirus etiology of oral cavity papillomas
63. A human papillomavirus closely related to HPV13 found in a focal epithelial hyperplasia lesion (Heck's disease)
64. Detection of human papovavirus antigen in oral papillary lesions
65. Human papillomavirus types in oral verruca vulgaris
66. Identification of genital tract papillomaviruses HPV-6 and HPV-16 in warts of the oral cavity
67. Characterisation of human papillomavirus type 13 from lesions of focal epithelial hyperplasia Heck
68. A new type of human papillomavirus associated with oral focal epithelial hyperplasia
69. Detection of human papillomavirus (HPV) DNA in focal epithelial hyperplasia
70. Two newly identified human papillomavirus types (HPV 40 and 57) isolated from mucosal lesions
71. Unusual HPV types in oral warts in association with HIV infection
72. Cell mediated immunity to herpesvirus type 1 in carcinoma and pre-cancerous lesions
73. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man
74. Squamous cell carcinoma associated with canine oral papillomavirus
75. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis
76. Verrucous carcinoma: a possible viral pathogenesis
77. Papillomavirus DNA in human tongue carcinomas
78. Human papillomavirus type 2 DNA in oral verrucous carcinoma
79. Detection of papillomavirus DNA in oral papillomas and carcinomas: application of in situ hybridization with biotinylated HPV16 probes
80. Human papillomavirus (HPV) DNA sequences in oral precancerous lesions and squamous cell carcinoma demonstrated by in situ hybridisation
81. A survey of human cancers for HPV DNA by filter hybridisation
82. High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan
83. Detection of human papillomavirus DNA in biopsies of human oral tissue
84. Human papillomavirus DNA in biopsies of oral tissues
85. Detection of human papillomavirus genes in human oral tissue biopsies and cultures by polymerase chain reaction
86. Papillomaviruses: the current status in relation to oral disease
87. Evidence of prevalent genital-type human papillomavirus infections in adults and children
88. Genital-oral transmission of human papillomaviruses
89. Expression of p53 in premalignant and malignant squamous epithelium